← SynDRA
DARIDOREXANT
SynDRA canonical compound SYN0039688 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Approval status | Approved · Rx |
|---|
| Primary target(s) | HCRTR1 | HCRTR2 |
|---|
| Mechanism of action | orexin receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- HCRTR2 ANTAGONIST
- Orexin receptor antagonist
- HCRTR1 ANTAGONIST
- Orexin receptor 1 antagonist
- Orexin receptor 2 antagonist
Drug classes
- Orexin Receptor Antagonists
- Orexin Receptor Antagonist
ATC classes
- N05C · HYPNOTICS AND SEDATIVES
Cross-references
Synonyms
- quviviq
- daridorexant hydrochloride
- ACT-541468
- nemorexant
- Nemorexant
- DEA NO. 2410
- LMQ24G57E9
- Quviviq
- daridorexantum
- RefChem:56310
- DTXCID901766549
- Daridorexant [USAN]
- MFCD31630772
- ACT 541468;ACT-541468
- Nemorexant?
- ACT541468
- Daridorexant free base
- Nemorexant;?Daridorexant
- nemorexant (former name)
- DARIDOREXANT [INN]
- UNII-LMQ24G57E9
- Nemorexant (DISCONTINUED)
- DARIDOREXANT [WHO-DD]
- orb1473166
- SCHEMBL16766318
- SCHEMBL16778804
- SCHEMBL30028832
- EX-A7813A
- GTPL11648
- BDBM334973
- GLXC-15297
- FKC48482
- WHO 10679
- US9732075, Example 5.36
- AKOS040742277
- DA-66016
- SY251586
- HY-109095
Reported adverse events
- Dizziness
- Hallucination
- Headache
- Hypersensitivity
- Nausea
- Sleep paralysis
- Somnolence
- Cataplexy
- Depression
- Nightmare
Look up DARIDOREXANT in the interactive SynDRA portal →